![Yann Echelard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yann Echelard
Direktor/Vorstandsmitglied bei
TG THERAPEUTICS, INC.
Vermögen: 8 Mio $ am 31.05.2026
Profil
Dr. Yann Echelard is a Founding President at Ampersand Biomedicines, Inc., an Operating Partner at Flagship Pioneering, Inc. and an Independent Director at TG Therapeutics, Inc. He is on the Board of Directors at TG Therapeutics, Inc., Hema Biologics and LFB USA, Inc. Dr. Echelard was previously employed as a President by Profound Therapeutics, Inc., a President, Chief Executive Officer & Director by rEVO Biologics, Inc., a Founding President by Cellarity Inc., a President by Laronde, Inc., and a Founding President by Ring Therapeutics, Inc. He also served on the board at GTC Biotherapeutics UK Ltd. He received his doctorate degree from the University of Montréal.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
TG THERAPEUTICS, INC. 0,15 % | 11.06.2026 | 223.816 ( 0,15 % ) | 8 Mio $ | 31.05.2026 |
Aktive Positionen von Yann Echelard
| Unternehmen | Position | Beginn |
|---|---|---|
| TG THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 09.11.2012 |
Hema Biologics
 Hema Biologics Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direktor/Vorstandsmitglied | - |
LFB USA, Inc.
 LFB USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicinal products | Direktor/Vorstandsmitglied | - |
Flagship Pioneering, Inc.
 Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Private Equity Investor | 01.10.2018 |
Ampersand Biomedicines
 Ampersand Biomedicines BiotechnologyHealth Technology Engages in creating and programming therapeutics & drug development | Gründer | 01.01.2021 |
Ehemalige bekannte Positionen von Yann Echelard
| Unternehmen | Position | Ende |
|---|---|---|
| REVO BIOLOGICS INC | Vorstandsvorsitzender | 01.04.2018 |
GTC Biotherapeutics UK Ltd. | Direktor/Vorstandsmitglied | 01.12.2010 |
Profound Therapeutics
 Profound Therapeutics Pharmaceuticals: OtherHealth Technology Develops human proteome therapeutics discovery services | Gründer | - |
Laronde Inc.
 Laronde Inc. Miscellaneous Commercial ServicesCommercial Services Develops an eRNA therapeutic platform that capable diverse proteins inside body | Gründer | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Yann Echelard
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
50
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
TG Therapeutics, Inc.
 TG Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
University of Montréal
 University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
rEVO Biologics, Inc.
 rEVO Biologics, Inc. BiotechnologyHealth Technology Develops and commercializes specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions | Health Technology |
LFB USA, Inc.
LFB USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicinal products | Health Technology |
GTC Biotherapeutics UK Ltd. | |
Hema Biologics
Hema Biologics Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transforming commensal viruses therapies | Health Technology |
Cellarity Inc.
 Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | Technology Services |
Laronde Inc.
Laronde Inc. Miscellaneous Commercial ServicesCommercial Services Develops an eRNA therapeutic platform that capable diverse proteins inside body | Commercial Services |
Profound Therapeutics
Profound Therapeutics Pharmaceuticals: OtherHealth Technology Develops human proteome therapeutics discovery services | Health Technology |
Ampersand Biomedicines
Ampersand Biomedicines BiotechnologyHealth Technology Engages in creating and programming therapeutics & drug development | Health Technology |
